Ticker
ZVRACompany Name
ZEVRA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Liabilities | Working Capital |
---|---|---|---|
6/30/2025 | $ 226.34M | $ 28.83M | $ 197.5M |
3/31/2025 | $ 81.57M | $ 26.98M | $ 54.6M |
12/31/2024 | $ 86.03M | $ 34.06M | $ 51.96M |
9/30/2024 | $ 99.44M | $ 34.48M | $ 64.96M |
6/30/2024 | $ 60.89M | $ 30.45M | $ 30.44M |
3/31/2024 | $ 62.89M | $ 29.91M | $ 32.98M |
12/31/2023 | $ 86.94M | $ 73.72M | $ 13.22M |
9/30/2023 | $ 137.01M | $ 21.71M | $ 115.3M |
6/30/2023 | $ 103.43M | $ 18.25M | $ 85.17M |
3/31/2023 | $ 104.28M | $ 15.62M | $ 88.66M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for ZEVRA THERAPEUTICS INC is calculated as follows: AssetsC [ $ 8.14M ] - LiabilitesC [ $ 70.8M ]
(=) Working Capital [ $ -62.65M ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 2.79K |
---|---|
min | $ -457.39M |
max | $ 607.04M |
average | $ 96.42M |
median | $ 32.11M |
std | $ 173.65M |